Introduction
A number of diseases are associated with glucose transport and metabolism defects, such as myocardial ischemia , type 2 diabetes
, or cancer , . The development of new radiolabeled glucose analogues for the non-invasive assessment of glucose uptake by 2 ]
[3 4 ] nuclear imaging is therefore of great clinical interest.
F -2-fluoro-2-deoxy-D-glucose (FDG) is the only radiolabeled glucose analogue [ 18 ] to be currently used clinically with Positron Emission Tomography (PET) in cardiology , , neurology , , and more recently in 
In this study, the biological behavior of four original glucose analogues iodinated in position [9 10 11 12 13 14 15 16 17 ] 3, 4 and 6 proposed as tracers of glucose uptake was investigated. A tracer of glucose uptake should enter the cells via the glucose in vivo transporters (GLUTs) and accumulate intracellularly without being further metabolized or degraded for a period long enough to allow SPECT imaging. Each tracer should therefore present several performance characteristics such as tissue selectivity, high cellular uptake, good affinity for the GLUTs, strong retention, and good interaction with hexokinase. In the present study, mouse biodistribution in vivo experiments were performed in order to demonstrate a potential accumulation of the iodinated glucose analogues in an organ. Two in vitro models were also used to investigate the cellular uptake mechanisms of the tracers. Human erythrocytes have been widely used to study glucose uptake because glucose transporters are highly expressed within their cellular membranes . However, as erythrocytes mainly France).
Synthesis

3
-iodomethyl-, -D-glucopyranoside (3IMG) ( ) was obtained by addition of an iodomethyl group on carbon 3 of the -C α β Fig. 1a glucose molecule. 4-deoxy-4-iodo-D-glucose (4DIG) ( ) was prepared according to the method of Abbadi . 4--(2 Fig. 1b et al. [19 ] O ′ 2 11
-iodoethyl)-, -D-glucopyranoside (4IEG) ( ) was obtained by grafting the stable -iodoethoxyl group to position 4 . 6 -(4
) was prepared by addition of an iodophenyl group to position 6. α β Fig. 1d 
Radiolabeling of glucose analogues
The labeling of 3IMG and 4IEG was performed by I-I isotopic exchange using the method of Mathieu . Five 125 127 et al. [21 ] milligrams of the unlabeled glucose analogue were dissolved into 1 mL of a Na I solution (2 g/mL) in acetone before being added to a 127 μ solution of sodium iodide I in 0.02 M NaOH. The mixture was heated at 105 C for 60 minutes. Following cooling, acetone was 125 °e liminated by evaporation under vacuum and the glucose analogue was dissolved into physiologic medium (NaCl 0.9 ). After labeling, % free iodides typically representing 20 40 of the total activity were removed by filtration on an anionic resin (AG1-X8 200 400 mesh, -% -Bio Rad). The radiochemical purity was higher than 95 . The radiolabeling of 4DIG was performed using the tetraacetyl precursor with a % triflate group in position 4. 1.3 mg of this precursor was dissolved into 1 mL of a Na I solution (1 g/mL) in acetone. Na I was then 
Biological procedures
In vivo studies: mouse biodistribution
Female Swiss mice (average weight 20 g) received 50 L of a solution of the iodinated glucose analogue (7.4 kBq/mouse) in isotonic μ NaCl 0.9 . The animals were euthanized at 2, 5, 10, 15 and 60 minutes post-injection (pi). The heart, diaphragm, liver, lung, kidney, % muscle, white fat and brain were excised, rinsed, weighed and counted in a scintillation counter (Novelec). Tracer organ uptake was γ expressed as injected dose/g wet weight tissue ( ID/g). Another group of mice was used to evaluate blood kinetics at the same time % % points. Tracer blood activity was expressed as injected dose/mL of blood ( ID/mL).
% %
In vitro studies: human erythrocytes
Human erythrocyte suspensions were prepared from whole blood according to the method of Levine . Erythrocytes were et al. [22 ] preincubated at 25 C or at 4 C to evaluate the effect of temperature on the cellular uptake of the tracers. The effect of the glucose°°t ransporter inhibitor cytochalasin B (50 M) on the cellular uptake kinetics of the iodinated glucose analogues was also studied by the uptake of iodinated glucose analogues by adipocytes was measured by gamma-well counting of the radioactivity (Novelec). The number of adipocytes was measured according to the method of Dole . All experimental protocols on isolated rat adipocytes were [25 ] validated by studying the effect of cytochalasin B, insulin, and increasing extracellular glucose concentrations on the cellular uptake of the gold-standard tracer for glucose uptake, C -2-deoxy-D-glucose (2-DG) ( and ). 2-DG uptake increased over time to reach Table 2 a value of 10 nmol/10 cells after 30 min. Insulin significantly stimulated tracer uptake from 5 to 30 min with a 3-fold increase at 30 min.
6
Cytochalasine B inhibited 2-DG uptake by 80 at 15 min. The D-glucose effect on 2-DG uptake was significant for concentrations above % 10 mM These results therefore validated the use of isolated rat adipocytes as an experimental model for the study of new radiolabeled glucose analogues.
In vitro assessment of iodinated glucose analogue phosphorylation
phosphorylation studies were performed on non-radioactive iodinated glucose analogues (6 mM) in the presence of the In vitro hexokinase enzyme (100 units/L) and adenosine 5 -triphosphate (ATP, 0.1 mM) in the kit medium at room temperature. After 30 and 60 ′ min, High-Performance Liquid Chromatography (HPLC, 254 nm) was performed to quantify the disappearance of ATP molecules, λ = reflective of the glucose analogue s phosphorylation state. Positive controls were performed using D-glucose (6 mM) and showed ' near-complete disappearance of ATP.
Statistical analysis
Results are presented as mean standard deviation. Comparisons were performed using unpaired Students t test.
± '
Results
In vivo studies: mouse biodistribution ( ) Myocardial activity of 3IMG was approximately 5 ID/g at 2 min pi but decreased over time in the myocardium as well as Table 1 % in other organs. 4DIG activity was stable for up to 10 min in the myocardium and 15 min in skeletal muscle (2.75 0.40 ID/g at 2 min pi ± % and 2.73 0.30 ID/g at 15 min pi in skeletal muscle for example, NS). In the brain, 4DIG activity was low but increased between 2 and ± % 15 min pi (p < 0.001). The most part of 4IEG and 6IPG radioactivity was found in kidneys at 2 min pi (33.6 2.4 ID/g for 4IEG and ± % 70.58 23.46 ID for 6IPG) with almost no brain uptake. In summary, kidneys were the major organ of excretion for all iodinated ± % glucose analogues. In addition, no major specific organ accumulation was observed with all tracers tested.
In vitro studies: human erythrocytes
Uptake kinetics
Uptakes of 3IMG and 4DIG by erythrocytes at 25 C strongly increased from 1 to 5 min (p < 0.001) and then remained stable until 60°m in ( ). Uptakes of 4IEG and 6IPG at 25 C were low but also increased between 1 and 60 min (p < 0.001) ( ). A  Fig. 3a, 3b °Fig. 3c, 3d significant decrease in the cellular uptake of all iodinated glucose analogues was observed when decreasing the temperature at which the experiments were performed from 25 to 4 C. Cytochalasin B had no effect on 3IMG uptake, with the exception of 15-min time point when°a 55 inhibition was observed (p < 0.01). This inhibitor reduced 4DIG uptake from 5 min to 60 min (p < 0.05). However, this inhibition % remained inferior to 50 . Cytochalasin B had no effect on 4IEG and 6IPG uptake, except at 60 min for 6IPG ( , p<0.01).
%
Fig. 3d
Competition with D-glucose ( ) Table 2 A preincubation with increasing concentrations of D-glucose from 2.5 to 20 mM significantly decreased 3IMG uptake (p < 0.001).
Likewise, 4DIG uptake was partially decreased in the presence of D-glucose at 2.5, 5 and 10 mM (p < 0.05). On the other hand, increasing the extracellular concentration of D-glucose did not affect 4IEG or 6IPG uptake. Table 3 There was rapid washout of 3IMG from erythrocytes as only 5 of the initial radioactivity remained after 1 min. Cytochalasin B % significantly slowed down 3IMG washout between 5 min and 30 min (p < 0.001). The washout of 4DIG was rapid as well, as only 8 of % the initial radioactivity remained associated to the cells after 1 min. Cytochalasin B decreased this washout as approximately 50 of the % initial radioactivity still remained in the erythrocytes after 15 min (p < 0.001 no cytochalasine B at the same time point). The versus washout of 4IEG was slower than that of 3IMG and 4DIG. Cellular tracer activity was still 50 of the initial value after 30 min of % washout. Cytochalasin B had no effect on 4IEG washout from erythrocytes. The washout of 6IPG was slow, as 30 of the initial % radioactivity remained associated to the cells after 1 min. Cytochalasin B had no significant effect.
Kinetics of washout ( )
Isolated Rat Adipocytes
Kinetics of uptake
observed with 2-DG between 5 and 15 min ( ). 6IPG uptake was the greatest with ~10 nmoles/10 cells. 4DIG uptake was increased 0.05), on 4IEG uptake at 5 min (p < 0.05) and on 6IPG uptake at 5 min (p < 0.01) and 15 min (p < 0.05). However, these effects were lower than those observed on 2-DG uptake ( ). Fig. 2 
Competition with D-glucose
An increase of D-glucose concentration in suspension medium from 2.5 to 20 mM had no effect on the uptake of the four iodinated analogues on adipocytes ( ). Table 2 In vitro assessment of iodinated glucose analogue phosphorylation
No decrease in ATP concentration was observed for all four iodinated glucose analogues after 30 and 60 min of incubation in the presence of hexokinase, indicating no phosphorylation of the compounds.
Discussion
The aim of this study was to assess the biological behavior of new iodinated glucose analogues proposed as tracers of glucose uptake This work is the final part of a systematic study initiated a few years ago, which consisted in adding an iodine atom on all free in vivo.
positions of the glucose molecule and in evaluating the potential interaction of these new molecules with glucose transporters on different biological models , . A radiolabeled glucose analogue iodinated on position 6 has previously been shown to interact with the [14 23 ] glucose transporter, in a manner similar to that of the tracer of glucose transport 3-O-methyl-D-glucose (3-OMG)
. But none of the [11 ] tracers evaluated so far behaved as a tracer of glucose uptake , , ,
However, all labeling options for the [9 10 11 12 13 14 15 16 17 ] glucose molecule had not been evaluated yet. New chemical synthesis strategies have been proposed, which enabled the labeling on the positions 3, 4, and 6 of the glucose molecules. The specific aim of this study was therefore to evaluate the biological behavior of four new glucose analogues iodinated in position 3, 4 and 6 and proposed as tracers of glucose uptake equivalent to 2-Deoxy-D-Glucose (2-DG). To be tracers of cellular glucose uptake, these iodinated glucose analogues should present several performance characteristics such as tissue selectivity, high cellular uptake, good affinity for the GLUTs, strong retention, and good interaction with hexokinase. As previously described by Henry et al.
, the reference tracer of glucose uptake 2DG presented all these performance characteristics. The tracer was [23 ] selective for the heart with myocardial uptake reaching 22 ID/g at 15 min pi . In human erythrocytes, 2DG uptake increased linearly % [23 ] between 1 and 60 min at 25 C. Cytochalasine B induced a 74 inhibition of tracer uptake at 60 min and increasing the extracellular°% concentration of D-glucose was associated with a progressive decrease in 2DG uptake, demonstrating that 2DG cellular uptake was mediated by GLUTs. Finally, 2DG remained within the cell after being phosphorylated by hexokinase . To study the effect of insulin, [26 ] which stimulates glucose transport, the model of rat adipocytes in suspension was used in the present study. 2DG uptake was in vitro increased by 3-fold in the presence of insulin in this model ( ). The new iodinated glucose analogues should therefore present the Fig. 2 same behavior if they are tracers of glucose uptake.
Analogue iodinated in position 3 of the glucose molecule
None of the glucose analogues iodinated in position 3 proposed so far has shown a biological behavior similar to that of 2-DG , , [9 12 , , , . However, 3-OMG is methylated in position 3 and is still recognized by the glucose transporter. This position was 13 14 27 28 ] therefore interesting for adding an iodine atom considering that the steric hinderance of this radioisotope is similar to that of a methyl group. Bessel have shown that the hydroxyl group in position 3 of the glucose molecule is necessary for the recognition of et al. [29 ] glucose by hexokinase. 3-OMG is therefore not a substrate for hexokinase due to the presence of a methyl group on carbon 3 and is not trapped in the cells. The glucose analogue 3IMG evaluated in the present study was then synthesized with a free hydroxyl group on carbon
(
). 3IMG therefore potentially retains the capability to interact with hexokinase and to be trapped in the cell. Stabilization of the Fig. 1a iodine atom on the glucose molecule was performed by using an iodomethyl group. After 3IMG radiolabeling through isotopic exchange, HPLC analysis showed a chemical stability exceeding 24 hours. Two min after injection in the mouse, high 3IMG kidney activity in vivo was observed, and tracer organ activity decreased in all organs over time without demonstrating any tissue selectivity. In erythrocytes, a rapid clearance of the molecule was observed. The effects of temperature, cytochalasin B, insulin and D-glucose were variable and not easily interpretable, demonstrating no clear interaction of the molecule with glucose transporters. Moreover, the phosphorylation in vitro assay indicated that 3IMG is not a substrate for hexokinase. These results suggest that 3IMG is not an iodinated analogue of 2-DG.
Analogues iodinated in position 4 of the glucose molecule
Only two glucose analogues iodinated in position 4 have been described so far: 4-O-(E)-3-iodopropen-2-yl-D-glucose and
No biological studies have been performed using these molecules. Glucose
On the other hand, the glucose analogue modified in position 4, 4-deoxy-4-fluoro-D-glucose, is [32 ] phosphorylated at a very slow rate by hexokinase . Nevertheless, this radiolabeling position has not been extensively studied. Two [29 ] glucose analogues have been studied in the present work: 4DIG, in which the hydroxyl group in position 4 of the glucose molecule was replaced by iodine, and 4IEG, which differs more from the original glucose molecule than 4DIG on a structural point of view, but which is also probably more chemically stable than this latter compound . In the mouse, cardiac radioactivity of 4DIG was [33 ] 4DIG. approximately 6 7 ID/g 10 min following intravenous injection. 4DIG skeletal muscle activity was stable (~3 ID/g) and radioactivity -% % in the brain increased slightly from 2 to 15 minutes. This behavior seemed to be interesting even if uptakes were slightly inferior to in vivo those of 2-DG . In human erythrocytes, temperature decreased 4DIG uptake by 50 to 60 . A decrease in temperature reduces [23 ] % membrane fluidity and consequently decreases the simple and facilitated diffusion of a given molecule. This result suggests that 4DIG
interacted with cytoplasmic membranes. Cytochalasin B decreased 4DIG uptake by 30 to 40 at 5 minutes, while a 90 decreased of % % 2-DG uptake was observed at 5 minute . On isolated rat adipocytes, the only significant effect of cytochalasin B was observed at 15 [23 ] minutes. On the other hand, cytochalasin B markedly inhibited the cellular washout of 4DIG from erythrocytes as 47 of the initial % activity remained after a 15-min washout when the glucose transporter inhibitor was present as opposed to 4 in its absence. These results indicated an interaction between 4DIG and glucose transporters during the cellular washout of the tracer. However, the cellular uptake of 4DIG does not occur through glucose transporters and the molecule is not phosphorylated. Therefore, this tracer cannot be considered as an equivalent of 2-DG.
Biodistribution of 4IEG in the mouse showed high kidney uptake of the tracer at 2 minutes (~35 ID/g). In 4IEG.
% all organs, the clearance was rapid with the exception of the brain where nearly no tracer uptake was observed. In human erythrocytes, 4IEG uptake was low but increased with time and a decrease in temperature strongly decreased cellular tracer uptake by 80 at 60 % minutes. This result suggests that 4IEG interacted with cytoplasmic membranes. Cytochalasin B had no major effect on 4IEG uptake and washout both in erythrocytes and adipocytes. Moreover, neither D-glucose nor insulin had a significant effect on 4IEG uptake indicating no affinity for the glucose transporter. Finally, this molecule was not phosphorylated by hexokinase. These results were very in vitro similar to those obtained by Henry with L-1-C -glucose, which enters into the cell via passive diffusion and is not further et al. [23 ] [ 14 ] metabolized . 4IEG does not present the performance characteristics expected and is therefore not a tracer of glucose uptake. [18 ] Analogue iodinated in position 6 of the glucose molecule
None of the glucose analogues iodinated in position 6 and previously described in the literature was phosphorylated by hexokinase, probably because of the substitution of the hydroxyl group by an iodine atom , , , . In this study, 6IPG was radiolabeled by [11 15 20 34 ] substitution of the hydrogen on the C6 position with an iodine atom such as with 3IMG. The hydroxyl group in position 6 remained therefore potentially available for phosphorylation by the hexokinase enzyme. The aromatic cycle carrying the iodine atom is a very good stabilizing group, and two glucose analogues with substitution on the C6 position, 6-C-phenyl-L and D -glycerol-D-glucopyranose, have [ ] been described as inhibitors of the glucokinase enzyme . An interaction between 6IPG and hexokinase is therefore possible. As [35 ] observed for position 4, position 6 does not play a major role in the recognition of the glucose molecule by glucose transporters during cellular uptake. Indeed, 6-deoxy-6-iodo-D-glucose, in which the hydroxyl group in position 6 that has been substituted by an iodine atom, has shown a behavior similar to that of 3-OMG, the reference tracer of glucose transport . Two minutes after injection in the mouse,
6IPG was mostly found in the kidney (~70 ID/g). Tracer uptake by erythrocytes was slow and not markedly affected by temperature % decrease. Cytochalasin B effect on 6IPG uptake by erythrocytes and adipocytes was also weak and the glucose transporter inhibitor did not inhibit the cellular washout of the tracer. Neither D-glucose nor insulin had an effect on the cellular uptake of this molecule, and 6IPG was not a substrate for hexokinase . Taken together, the results indicate that 6IPG does not interact with glucose transporters and is not in vitro phosphorylated. 6IPG cannot be considered as a tracer of glucose uptake.
The main findings of this study are summarized in the 
